MK

Manish Kumar

Active Director Designated Partner DIN 10161004
DIN 10161004 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Kumar

Data last updated:

Manish Kumar is a Designated Partner at Drugreat Pharmaceuticals Llp (since 2023). The company operates in Business Services.

DIN 10161004
Primary Designation Designated Partner
Industry Business Services
First Appointment 12 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 May 20232023Active

Board colleagues of Manish Kumar

NameDINCompanyDesignation
Shalini Biala10161002Drugreat Pharmaceuticals LlpDesignated Partner
Srishti Kumar05173095Drugreat Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Drugreat Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Manish Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Kumar

Manish Kumar currently holds 1 directorship: Drugreat Pharmaceuticals Llp (Designated Partner, since 12 May 2023).

Manish Kumar was first appointed on 12 May 2023 as Designated Partner at Drugreat Pharmaceuticals Llp.

The current boards of Manish Kumar's companies include Shalini Biala (Drugreat Pharmaceuticals Llp), Srishti Kumar (Drugreat Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available